In partnership with

The Power Play Behind Canada’s Hottest Energy Stock

Ticker: CCO.TO | Sector: Energy | Industry: Uranium

🌍 Official Website: https://www.cameco.com

📊 Wealth Awesome Stock Page: https://wealthawesome.com/stock/cco-to/

Cameco (TSX: CCO) continues to light up the markets with massive momentum in 2025 — rising over 90% year-to-date and recently surging 20% in a single month. Investors are piling in as uranium prices stay elevated and global nuclear energy demand accelerates .

Seeking impartial news? Meet 1440.

Every day, 3.5 million readers turn to 1440 for their factual news. We sift through 100+ sources to bring you a complete summary of politics, global events, business, and culture, all in a brief 5-minute email. Enjoy an impartial news experience.

Major Developments This Week

  • Market Performance: Cameco jumped +16.9% this week, reaching $141.73 before easing slightly. The rally was fueled by optimism ahead of its Q3 earnings report on Nov 5, 2025, where investors expect another blockbuster quarter.

  • Sector Tailwind: Renewed policy support for nuclear energy in North America and Europe continues to boost uranium stocks, with Cameco leading the pack.

  • Westinghouse Strength: The company’s acquisition of Westinghouse keeps driving higher margins and diversified revenue streams, solidifying its position as a global nuclear leader.

Key Metrics

Metric

Value

Stock Price

$141.73 (-1.12%)

Weekly Move (5-day)

+16.9%

Market Cap

US$44.0B

P/E Ratio (TTM)

116.3

Forward P/E Ratio

68.1

52-Week Range

$49.75 – $153.59

YTD Return

+91.8%

Dividend Yield (fwd)

0.1%

Cameco’s valuation looks stretched — but strong fundamentals and earnings momentum may justify it, especially in a supply-constrained uranium market.

Analyst Insights

Insight

Detail

Consensus Rating

STRONG BUY

Average Target Price

$133.11

Upside Potential

-6.08% (price above target)

Breakdown (15 analysts)

Strong Buy: 11 · Buy: 4 · Hold: 0 · Sell: 0

Analysts remain overwhelmingly bullish, though the current rally has outpaced targets — suggesting a short-term cooldown may be healthy before the next leg up.

Recent News Highlights

  1. Uranium Prices Surge: Prices touched multi-year highs amid renewed demand for clean, reliable nuclear energy. Cameco’s production outlook positions it as a top beneficiary.

  2. Westinghouse Integration Continues 🔧: Analysts highlight Cameco’s operational synergies post-acquisition, with improved margins in the fuel services division.

  3. Pre-Earnings Buzz: Ahead of Q3 (Nov 5), estimates point to continued earnings beats as long-term contracts roll in at higher uranium prices.

Growth Indicators

Growth Metric

Value

Sales Growth (Next Year)

+9.1%

EPS Growth (Next Year)

+35.7%

5-Year EPS Growth Estimate

-136.7% (volatile)

Despite an overstated 5-year EPS decline (driven by 2020–21 base effects), short-term earnings momentum remains phenomenal, with multiple analyst upgrades this month.

Quality, Value & Financial Strength

  • Profitability: Solid 17.8% operating margin and 14.9% net margin, well above uranium peers.

  • Balance Sheet: Excellent D/E ratio of 0.2 and current ratio of 3.0 — Cameco’s liquidity is strong.

  • Momentum: RSI 67.1 and Price vs 52-week low: +285% — strong but nearing overbought territory.

Quick Snapshot

Aspect

Detail

Thesis

Nuclear energy’s resurgence + Cameco’s dominant market share = long-term growth

Catalysts

Nov 5 earnings, uranium supply contracts, policy incentives

Risks

Overvaluation, uranium price volatility, geopolitical exposure

Investor Type

Growth investors seeking energy transition exposure

Myth: Pet insurance doesn’t cover everything

Many pet owners worry that insurance won’t cover everything, especially routine care or pre-existing conditions. While that’s true in many cases, most insurers now offer wellness add-ons for preventive care like vaccines, dental cleanings, and check-ups, giving you more complete coverage. View Money’s pet insurance list to find plans for as low as $10 a month.

The Wealth Awesome Team

Reply

or to participate